Previous 10 | Next 10 |
BioLife Solutions ( BLFS ) is a stock to benefit from the early innings of regenerative medicine revolution with multiple avenues for growth ahead if it. Not only does it continue to gain new customers involved in clinical trials, but this also increases the pool of customers which eventuall...
BioLife Solutions, Inc. (BLFS) Q1 2019 Earnings Conference Call May 9, 2019 4:30 PM ET Company Participants Mike Rice – President and Chief Executive Officer Roderick de Greef – Chief Financial Officer Conference Call Participants Suraj Kalia – Northland ...
BioLife Solutions (NASDAQ: BLFS ): Q1 GAAP EPS of $0.02 misses by $0.01 . More news on: BioLife Solutions, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
BOTHELL, Wash. , May 9, 2019 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), the leading developer, manufacturer and marketer of proprietary biopreservation media and automated cell thawing media devices for cell and gene therapies, today...
BOTHELL, Wash. , May 2, 2019 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade biopreservation media for cell and gene therapies, ("BioLife" or the "Company"), today announced that the Company's fi...
BOTHELL, Wash. , April 2, 2019 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife") today announced that it has closed the previously announced transaction for the acquisition of Astero Bio Corporation ("Astero"), an innovator in the design, development and com...
In the long run, it's not just how much money you make that will determine your future prosperity. It's how much of that money you put to work by saving it and investing it. - Peter Lynch (stellar value and growth investor) On March 12, 2019, Osiris Therapeutics ( OSIR ) disclosed that S...
One of our top picks in the SHU portfolio is BioLife Solutions ( BLFS ), the maker of proprietary preservation solutions for cells, tissues, and organs. The company just presented Q4 and 2018 figures, as usual, we like to start with a little overview: Data by YCharts These are the kind o...
BioLife Solutions, Inc. (BLFS) Q4 2018 Earnings Conference Call March 14, 2019 04:30 PM ET Company Participants Roderick de Greef - Chief Financial Officer Michael Rice - President and Chief Executive Officer Conference Call Participants Paul Knight - Janney Jason McCarthy ...
BioLife Solutions (NASDAQ: BLFS ): Q4 GAAP EPS of $0.04 misses by $0.02 . More news on: BioLife Solutions, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
BioLife Solutions Inc. Company Name:
BLFS Stock Symbol:
NASDAQ Market:
BioLife Solutions Inc. Website:
BioLife Solutions to Report Second Quarter 2024 Financial Results and Business Update on August 8, 2024 PR Newswire BOTHELL, Wash. , July 25, 2024 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction...
BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouv...
BioLife Solutions Reports First Quarter 2024 Financial Results PR Newswire Cell Processing revenue increased 10% sequentially to $16.2 million GAAP gross margin of 38% and net loss of $10.2 million Non-GAAP adjusted gross margin expands ...